Phosphoinositide turnover enhanced by angiotensin II in isolated rat glomeruli. 1987

S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada

To clarify the signal transduction mechanism of angiotensin II in renal glomeruli, we studied the effect of the hormone on phospholipid metabolism using isolated rat glomeruli. Stimulation of the glomeruli pulse-chase labeled with [3H]glycerol by angiotensin II caused a rapid (within 15 s) breakdown of phosphatidylinositol 4,5-bisphosphate (PIP2) with a concurrent production of 1,2-diacylglycerol. This effect of angiotensin II was in a dose-dependent manner within the range from 10(-12) M to 10(-6) M, and was inhibited by saralasin. Angiotensin II also decreased the 3H radioactivity of PIP slightly only at 15 s and increased that of phosphatidic acid after 15 s, with no significant effect upon the labelings of phosphatidylinositol (PI), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) within 1 min. The change in phospholipid metabolism by angiotensin II was similar when the glomeruli were labeled with [32P]orthophosphate: the decrease in the labeling of PIP2 and the increase in the labeling of phosphatidic acid after 15 s. In addition, 32P labeling of PI increased after 2 min. These results suggest that angiotensin II, after binding to glomerular receptors, induces initial PIP2 hydrolysis to diacylglycerol and subsequent resynthesis of PIP2 through phosphoinositide turnover.

UI MeSH Term Description Entries
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010712 Phosphatidic Acids Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups. Ammonium Phosphatidate,Diacylglycerophosphates,Phosphatidic Acid,Acid, Phosphatidic,Acids, Phosphatidic,Phosphatidate, Ammonium
D010716 Phosphatidylinositols Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids. Inositide Phospholipid,Inositol Phosphoglyceride,Inositol Phosphoglycerides,Inositol Phospholipid,Phosphoinositide,Phosphoinositides,PtdIns,Inositide Phospholipids,Inositol Phospholipids,Phosphatidyl Inositol,Phosphatidylinositol,Inositol, Phosphatidyl,Phosphoglyceride, Inositol,Phosphoglycerides, Inositol,Phospholipid, Inositide,Phospholipid, Inositol,Phospholipids, Inositide,Phospholipids, Inositol
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004075 Diglycerides Glycerides composed of two fatty acids esterified to the trihydric alcohol GLYCEROL. There are two possible forms that exist: 1,2-diacylglycerols and 1,3-diacylglycerols. Diacylglycerol,Diacylglycerols
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005990 Glycerol A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. 1,2,3-Propanetriol,Glycerin,1,2,3-Trihydroxypropane,Glycerine
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
March 1989, European journal of pharmacology,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
November 1980, The American journal of physiology,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
October 1990, Biochemical and biophysical research communications,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
February 1995, The American journal of physiology,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
December 1989, Kidney international,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
May 1986, Clinical science (London, England : 1979),
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
August 1988, Kidney international,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
February 1992, The American journal of physiology,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
November 1982, The Journal of clinical endocrinology and metabolism,
S Ochi, and Y Fujiwara, and Y Orita, and Y Tanaka, and S Shin, and T Takama, and A Wada, and N Ueda, and T Kamada
November 1983, Federation proceedings,
Copied contents to your clipboard!